Business Outline
Pipeline
IR
DWTI’s Approach
About DWTI
FAQ
Glossary
日本語
toggle navigation
Business Outline
Our business model
Core Technology
Pipeline
Ripasudil hydrochloride hydrate
H-1337
DW-1001
DW-1002
DW-5LBT
DWR-2206
IR
Management Policy
To Shareholders/Investors
Issues to be addressed
Business Risks
Corporate Governance
Financial Information
Earnings Highlights
Financial Position
Cash Flow
IR Library
Five Unique Features of DWTI
Business model
Successful launch (commercialization)
Focus on ophthalmology
Growth trajectory
Growth Strategies
IR News
IR Calendar
Stock Information
Stock Quote
IR Policy / Disclaimer
About DWTI
Corporate Profile
Corporate Philosophy
CEO Message
Board of Directors
History
TOP
IR
Financial Position
Financial Position
Total Assets (million yen)
Net Assets (million yen)
Equity Ratio (%)
Net Assets per Share (yen)
About IR Site
Earnings Highlights
Financial Position
Cash Flow
